MicrofluidX, the cell and gene therapy manufacturing platform, has raised £1.4M in Seed funding from investors that include Cambridge Angels group, UK Innovation & Science Seed Fund, Longwall Venture Partners, Moulton Goodies, and 88 Capital. MicrofluidX was founded by Antoine Espinet and Cesare M. Cejas in 2018.
The TechWatch Media Group audience is driving progress and innovation on a global scale. With its regional media properties (London, NYC, LA, Paris, Boston), TechWatch Media Group is the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the London business community and beyond. Find out more here.
